Dietary Supplements

Browse Dietary Supplements Content

The dietary supplement industry’s leading trade associations and the U.S. Anti-Doping Agency today joined in support of FDA actions to protect consumers from body-building products containing Selective Androgen Receptor Modulators illegally marketed as dietary supplements.

Nov 8, 2017

CHPA applauds AHPA’s new guidelines on Good Agricultural and Collection Practices and Good Manufacturing Practices for Botanical Material, and acknowledges their importance in helping to ensure the production and supply of high-quality herbal raw materials.

Oct 2, 2017

CHPA respectfully submits comments to the Commission notice regarding public interest issues raised by Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Ltd. (“Amarin”) in its Complaint concerning Omega-3 (ω-3) products.

Sep 14, 2017

On behalf of the CHPA Dietary Supplements Committee, we are writing to express our concern with the recent decision by the Joint Committee to include certain elements of 21 CFR 117 within the consensus-based standard for dietary supplements.

Aug 23, 2017

Herein CHPA provides comments on several questions from the U.S. Department of Agriculture’s Agricultural Marketing Service regarding the establishment of a National Bioengineered Food Disclosure Standard.

Jul 17, 2017

The dietary supplement industry’s self-regulatory coalition, the SIDI Work Group, today released an updated draft of the “Standardized Information on Dietary Ingredients (SIDI) Protocol,” and seeks feedback from industry stakeholders and regulators by July 3, 2017.

Jun 1, 2017

CHPA applauds CRN and UL for spearheading the Supplement OWL, which will prove to be a valuable resource for regulators, retailers and ultimately consumers.

Apr 13, 2017

CHPA appreciates this opportunity to provide comments on FDA Guidance detailing the agency’s process for evaluating data on the beneficial physiological effects of isolated or synthetic non-digestible carbohydrates.

Feb 13, 2017

CHPA believes that FDA’s revised 2016 Draft Guidance is an important step in helping to improve manufacturer understanding of, and compliance with, the new dietary ingredient notification requirement in Section 413 of the Federal Food, Drug, and Cosmetic Act.

Dec 12, 2016

Filter Results